This inventor holds 4 USPTO granted patents. Top assignee: Mitsubishi Petrochemical Company Limited. Active years: 1978-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Amimachi, JA (1978)
- Ami, JP (1981)
- Ibaraki, JP (1992 - 1993)
Company Filing History:
Years Active: 1978-1993
Title: Eiji Taniyama: Innovator in Amino Acid Derivatives
Introduction
Eiji Taniyama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of amino acid derivatives. With a total of 4 patents to his name, Taniyama's work has implications for various applications in medicine and biochemistry.
Latest Patents
Taniyama's latest patents include innovative methods for preparing amino acid derivatives. One of his notable inventions involves a novel gamma-carboxyglutamic acid and methods for preparing Gla^17 human osteocalcin and Glu^17 human osteocalcin. This process utilizes a protected L-gamma-carboxyglutamic acid, which is crucial for synthesizing these important peptides. Another patent focuses on the preparation of Y-carboxyglutamate derivatives, which are also integral to the synthesis of osteocalcin.
Career Highlights
Eiji Taniyama is currently associated with Mitsubishi Petrochemical Company Limited, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also enhanced the capabilities of his company in the field of biochemistry.
Collaborations
Taniyama has collaborated with esteemed colleagues such as Sachio Hirose and Takashi Kurihara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eiji Taniyama's contributions to the field of amino acid derivatives exemplify the impact of dedicated research and innovation. His patents reflect a commitment to advancing biochemistry and improving methodologies in peptide synthesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile